Literature DB >> 28713691

Cognitive correlates of neuroimaging abnormalities in the onset of schizophrenia: A case report.

Silvia Grassi1, Giulia Orsenigo1, Marta Serati1, Elisabetta Caletti1, Alfredo Carlo Altamura1, Massimiliano Buoli1.   

Abstract

Increasing evidence shows that cognitive impairment and brain abnormalities can appear early in the first episodes of schizophrenia, but it is currently debated how brain changes can correlate with clinical presentation of schizophrenic patients. Of note, this report describes the case of a young schizophrenic male presenting parietal magnetic resonance/positron emission tomography abnormalities and cognitive impairment, documented by specific neuropsychological tests. In our knowledge only few studies have investigated if neuropsychological abnormalities could be concomitant with both structural and functional neuroimaging. This case shows that impairment in specific cognitive domains is associated with structural/functional brain abnormalities in the corresponding brain areas (frontal and parietal lobes), supporting the hypothesis of disconnectivity, involving a failure to integrate anatomical and functional pathways. Future research would define the role of cognitive impairment and neurodegeneration in psychiatric nosography and, in particular, their role in the early phases of illness and long-term outcome of schizophrenic patients.

Entities:  

Keywords:  Magnetic resonance; Neuropsychology; Positron emission tomography; Schizophrenia

Year:  2017        PMID: 28713691      PMCID: PMC5491478          DOI: 10.5498/wjp.v7.i2.128

Source DB:  PubMed          Journal:  World J Psychiatry        ISSN: 2220-3206


Core tip: Schizophrenia is associated with impairment in executive function, verbal memory, verbal fluency and attention. Neuropsychological tests are associated with structural and functional brain alterations. This case report is an example of the potential correlation between clinical symptoms (e.g., cognitive impairment) and brain changes. These data may help in the prediction of possible outcome of schizophrenia patients.

INTRODUCTION

A number of data would indicate schizophrenia as a progressive neurodegenerative disorder[1] whose outcome is influenced by many biological and clinical factors[2]. Of note, recent literature shows that neuropsychological deficits at onset may predict the clinical course of illness[3] being often associated with frontal and parietal lobe dysfunctions[4-6]. Moreover, a recent trial found that brain abnormalities of schizophrenic patients change according to age at onset. In particular, early onset patients show parietal abnormalities, while adult onset patients exhibit frontal and temporal ones[7]. To our knowledge there are few studies[8-10] associating cognitive frontal and parietal deficits with structural [magnetic resonance (MR)] and functional neuroimaging [positron emission tomography (PET)] and the anatomical and functional relationships underlying this deficit remain to be elucidated. Dysconnectivity, a failure in functional integration, is considered a key mechanism in the pathophysiology of cognitive impairments (in particular working memory performance) in individuals with schizophrenia[11]. The present paper deals with a recent diagnosed schizophrenic patient showing frontal and parietal lobe MR/PET abnormalities clinically associated with deficits in the corresponding cognitive domains.

CASE REPORT

The patient was a 19-year-old man admitted in our department. The patient showed nor psychiatric comorbidity with an Axis I disorder neither personality disorders. A neurological exam, performed by a neurologist, was negative. Diagnosis of undifferentiated schizophrenia and exclusion of comorbid conditions were assessed through the administration of semi-structured interviews based on DSM-IV criteria (SCID I and II). Patient had family history for psychiatric disorders: The father was an alcohol abuser, one schizophrenic uncle (father’s brother) committed suicide and the grandmother in mother line was affected by bipolar disorder. At the admission in our ward the patient was drug-naïve and showed persecutory delusion, auditory hallucinations, thought/behavioural disorganization and a duration of untreated psychosis of 9 mo[12]. Baseline score at Positive and Negative Syndrome Scale[13] was 84, while baseline score at Brief Psychiatric Rating Scale was 55[14]. In the first days of admission patient underwent to neuropsychological tests, cerebral MR and cerebral PET. A neuropsychological battery was designed to encompass the areas believed to be affected by Schizophrenia[15]. Results and standard scores are summarized in Table 1. Patient’s neurocognitive performances provided evidence for impairment in the following domains: Executive function (Cognitive Estimation, Verbal fluency, Trail Making Test), verbal memory, verbal ability (Boston Naming Test, phonemic Verbal Fluency) and attention (Visual Search, Trail Making Test). In addition, the patient failed in two Wechsler Adult Intelligence Scale[16] subscales: Verbal Comprehension Index and Perceptual Organization Index.
Table 1

Neuropsychological results

TestPatient scoreNormal valueResultZ-score
Mini-mental state examination27.1924-29.19Normal0.45
Executive functions: Tower of London2520-36Normal-0.75
Frontal assessment battery15.9813.5-17.3Normal-0.95
Cognitive estimation task19.970-18Failed2.43
Bizarreness60-4Failed4
Problem solving: Raven’s progressive matrices29.0518.6-33.05Normal0.89
Assessment of cognitive impairment in memory
Verbal memory and learning
Digit Span5.753.75-8.75Normal-0.4
Verbal Learning10.506.50-21.50Normal-0.93
Recall of prose: Immediate and after 10 min3.508.00-27.50Failed-2.92
Spatial short-term memory (Corsi test)4.503.50-8.50Normal-1.20
Attention and speed information processing
Trail making test
Part A33< 93 sNormal
Part B, dual task161< 282 sNormal
Part B-A128< 186 sBorderline score-1.36
Visual search34.2531-51.25Borderline score
Verbal fluency
Phonemic2317-59Borderline score-1.43
Categories3225-58Normal-1.15
Language
Boston naming test3143-60Failed-4.82
Token test3229-36Normal-0.29
Wechsler adult intelligence scale-revisedGeneral IQ = 75 (verbal IQ = 81; performance IQ = 74)80-120Borderline score-2.50
VCI = 5.5; POI = 6.25

The standard scores, reported in the second column, are calculated considering a normal population. Our patient’s scores, adjusted for age, sex and education are shown in the first column next to each test. A score is considered pathological when the score is present less than 5% of the normal population. Sometimes normal scores are considered pathological due to the clinical condition and the global performance. VCI: Verbal comprehension index; POI: Perceptual organization index.

Neuropsychological results The standard scores, reported in the second column, are calculated considering a normal population. Our patient’s scores, adjusted for age, sex and education are shown in the first column next to each test. A score is considered pathological when the score is present less than 5% of the normal population. Sometimes normal scores are considered pathological due to the clinical condition and the global performance. VCI: Verbal comprehension index; POI: Perceptual organization index. MR was performed using a circular polarized head coil and included Turbo Spin-Echo T1-weighted sequences, T2-weighted sequences and FLAIR. Imaging in three planes was performed using 5-mm slice thickness. MR revealed normal-sized ventricles, normal-sized subarachnoidal spaces, no abnormalities in gray matter, but bilaterally soft hyper-intensities in superior parietal lobe[4] periventricular white matter. Fluorodeoxyglucose (FDG) was injected in condition of rest and fasting and after 30 min three-dimensional scan was performed. The images were compared to a cohort of normal ones. Fluoro-D-Glucose PET (Figures 1 and 2) showed glucose frontal and parietal lobes hypo-metabolism bilaterally. No further abnormalities in FDG distribution were observed.
Figure 1

D-glucose (fluorodeoxyglucose) positron emission tomography, transversal sections. Pointer 1 displays the frontal lobe hypo-metabolism; pointer 2 displays the parietal lobe hypo-metabolism.

Figure 2

Fluoro-D-glucose (fluorodeoxyglucose) positron emission tomography, coronal sections. Pointer 1 displays the frontal lobe hypo-metabolism; Pointer 2 displays the parietal lobe hypo-metabolism.

D-glucose (fluorodeoxyglucose) positron emission tomography, transversal sections. Pointer 1 displays the frontal lobe hypo-metabolism; pointer 2 displays the parietal lobe hypo-metabolism. Fluoro-D-glucose (fluorodeoxyglucose) positron emission tomography, coronal sections. Pointer 1 displays the frontal lobe hypo-metabolism; Pointer 2 displays the parietal lobe hypo-metabolism. MR and PET were performed by neuroradiologists collaborating within our department. Of note, neuropsychological results are consistent with outlined MR abnormalities and PET images (fronto-parietal abnormalities)[17].

DISCUSSION

The present case report confirms data from literature of early cognitive deficits in the course of schizophrenia[18,19] and neuroimaging parietal abnormalities in early onset schizophrenic patients[7,20,21]. In addition, the correspondence between cognitive deficits and morphological/functional brain alterations[22] contributes to clarify the influence of brain changes in schizophrenia clinical presentation as well as to support the hypothesis of schizophrenia as a neurodegenerative disorder[23,24]. Recent trials found that brain abnormalities are more severe in patients with a longer duration of illness[25-27], novel antipsychotics are promising molecules for their efficacy in stopping the neurodegenerative process[28,29]. In this context cognitive and neuroimaging follow-up of our case can be useful to discriminate if neurodegenerative process of schizophrenia progresses in the course of illness or it is specific of early stages[24,30,31]. Finally, it would be important in the future to define the role of neuroimaging abnormalities in influencing outcome. MR and PET could be useful tools to make diagnosis and to predict long-term course of schizophrenic illness.

COMMENTS

Case characteristics

A 19-year-old male patient with severe schizophrenia presentation.

Clinical diagnosis

Patient was hospitalized because of prominent persecutory delusion, auditory hallucinations, aggressiveness and thought/behavioural disorganization.

Differential diagnosis

Bipolar disorder, substance use disorder.

Laboratory diagnosis

Routine blood tests were resulted within normal limits.

Imaging diagnosis

At magnetic resonance imaging bilaterally soft hyper-intensities in superior parietal lobe periventricular white matter were detected, while positron emission tomography showed glucose parietal lobes hypo-metabolism bilaterally.

Pathological diagnosis

Schizophrenia, acute episode.

Treatment

Ziprasidone 80 mg × 2 and Gabapentin 300 mg × 3.

Related reports

Severe cognitive impairment as showed by neuropsychological tests.

Term explanation

Dysconnectivity means abnormal functional integration among brain regions resulting in impaired modulation of neurotransmitters.

Experiences and lessons

It is important to perform imaging evaluation and neuropsychological tests to better define long-term outcome of schizophrenia patients.

Peer-review

This case report is novel and well designed.
  31 in total

Review 1.  Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.

Authors:  A Carlo Altamura; William V Bobo; Herbert Y Meltzer
Journal:  Int Clin Psychopharmacol       Date:  2007-09       Impact factor: 1.659

2.  The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.

Authors:  S R Kay; L A Opler; J P Lindenmayer
Journal:  Br J Psychiatry Suppl       Date:  1989-11

3.  Inter- and intra-rater reliability of the Brief Psychiatric Rating Scale.

Authors:  A Flemenbaum; R L Zimmermann
Journal:  Psychol Rep       Date:  1973-06

Review 4.  What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia.

Authors:  Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2008-02-17       Impact factor: 9.306

5.  Schizophrenic WAIS pattern by diagnostic subtypes.

Authors:  S R Kay
Journal:  Percept Mot Skills       Date:  1979-06

Review 6.  Prefrontal activation deficits during episodic memory in schizophrenia.

Authors:  John D Ragland; Angela R Laird; Charan Ranganath; Robert S Blumenfeld; Sabina M Gonzales; David C Glahn
Journal:  Am J Psychiatry       Date:  2009-05-01       Impact factor: 18.112

7.  Parietal lobes in schizophrenia: do they matter?

Authors:  Murat Yildiz; Stefan J Borgwardt; Gregor E Berger
Journal:  Schizophr Res Treatment       Date:  2011-10-16

8.  The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome.

Authors:  Verity C Leeson; Thomas R E Barnes; Masuma Harrison; Elizabeth Matheson; Isobel Harrison; Stanley H Mutsatsa; Maria A Ron; Eileen M Joyce
Journal:  Schizophr Bull       Date:  2008-08-04       Impact factor: 9.306

9.  Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: a population-based study of first-episode psychosis.

Authors:  Taís M Minatogawa-Chang; Maristela S Schaufelberger; Adriana M Ayres; Fábio L S Duran; Elisa K Gutt; Robin M Murray; Teresa M Rushe; Philip K McGuire; Paulo R Menezes; Marcia Scazufca; Geraldo F Busatto
Journal:  Schizophr Res       Date:  2009-07-17       Impact factor: 4.939

10.  Prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study.

Authors:  Massimiliano Buoli; Alice Caldiroli; Gabriele Panza; Alfredo Carlo Altamura
Journal:  Psychiatry Investig       Date:  2012-11-14       Impact factor: 2.505

View more
  2 in total

Review 1.  Acute and Transient Psychotic Disorders: Newer Understanding.

Authors:  Savita Malhotra; Swapnajeet Sahoo; Srinivas Balachander
Journal:  Curr Psychiatry Rep       Date:  2019-11-04       Impact factor: 5.285

2.  Association between mitochondrial DNA and cognitive impairment in schizophrenia: study protocol for a Mexican population.

Authors:  Dulce Dajheanne García-de la Cruz; Isela Esther Juárez-Rojop; Carlos Alfonso Tovilla-Zárate; José Jaime Martínez-Magaña; Alma Delia Genis-Mendoza; Humberto Nicolini; Thelma Beatriz González-Castro; Crystell Guadalupe Guzmán-Priego; Nancy Adanelly López-Martínez; Javier Antonio Hernández-Cisneros; Francisco Caballero-Prado
Journal:  Neuropsychiatr Dis Treat       Date:  2019-06-28       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.